⌘K

Login Start Free

Home/Filings/4/0001104659-21-081993

4//SEC Filing

SHROTRIYA RAJESH C MD 4

Accession 0001104659-21-081993

CIK 0000895051other

View on SEC.gov Company Profile

Filed

Jun 15, 8:00 PM ET

Accepted

Jun 16, 4:02 PM ET

Size

5.4 KB

Accession

0001104659-21-081993

Insider Transaction Report

Form 4

Period: 2021-06-15

CASI Pharmaceuticals, Inc.CASI

SHROTRIYA RAJESH C MD

Director

Transactions

Award
Stock Option (Right to Buy)
2021-06-15+98.349→ 98,349 total
Exercise: $1.65Exp: 2031-06-15→ Common Stock (98,349 underlying)

Footnotes (1)

[F1]Stock option award will vest ratably quarterly to the end of the year.

Documents

1 file

4
tm2119809d4_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

CASI Pharmaceuticals, Inc.

CIK 0000895051

Entity typeother

Related Parties

1

filerCIK 0001193918

Filing Metadata

Form type: 4
Filed: Jun 15, 8:00 PM ET
Accepted: Jun 16, 4:02 PM ET
Size: 5.4 KB

View on SEC.gov